BED Calculator

What Is the Biologically Effective Dose (BED)?

The Biologically Effective Dose (BED) is a radiobiological metric used to compare the biological effect of different radiotherapy fractionation schedules. It accounts for total dose, dose per fraction, and the intrinsic radiosensitivity of the tissue being treated. BED is essential for evaluating whether a new treatment regimen is biologically equivalent to a standard protocol.

How the BED Calculation Works

BED is derived from the linear-quadratic (LQ) model, which describes cell survival after radiation exposure. The formula is:

BED = n × d × (1 + d / (α/β))

Where:

• n = number of fractions
• d = dose per fraction (Gy)
• α/β ratio = tissue-specific parameter (Gy)

The α/β ratio reflects the tissue's sensitivity to fraction size. Lower α/β values (e.g., 2–3 Gy for late-responding tissues like spinal cord) indicate greater sensitivity to fraction size changes. Higher values (e.g., 10 Gy for early-responding tissues like tumors) indicate less sensitivity.

How to Use This BED Calculator

1. Enter the total dose delivered (Gy).
2. Enter the dose per fraction (Gy).
3. Enter the α/β ratio for the tissue of interest (Gy).
4. The calculator will compute the BED value automatically.

No additional inputs are required. The result updates in real time as you adjust any parameter.

Interpreting the BED Result

The BED value itself is a number that represents the biological effectiveness of the regimen. Higher BED values indicate a greater biological effect. When comparing two regimens, the one with the higher BED is expected to produce a greater biological response in that tissue type.

Important considerations:

• BED is tissue-specific. A regimen's BED for tumor control (e.g., α/β = 10 Gy) will differ from its BED for normal tissue toxicity (e.g., α/β = 3 Gy).
• BED is a comparative tool, not an absolute measure of outcome. It helps determine equivalence or superiority between fractionation schedules.
• The LQ model is most accurate for fraction sizes between 1.5 Gy and 6 Gy. Outside this range, results should be interpreted with caution.

Common Mistakes When Using BED

• Using the wrong α/β ratio: Applying a tumor α/β value to normal tissue calculations (or vice versa) will produce misleading results.
• Confusing BED with EQD2: BED is not the same as the equivalent dose in 2 Gy fractions (EQD2). EQD2 is derived from BED but represents a different comparison.
• Ignoring overall treatment time: The standard BED formula does not account for repopulation. For regimens with extended treatment breaks, a time-corrected BED may be more appropriate.

Practical Use Cases for BED

• Comparing a hypofractionated regimen (e.g., 5 fractions of 6 Gy) to a standard regimen (e.g., 30 fractions of 2 Gy) for tumor control probability.
• Evaluating whether a dose escalation protocol increases the risk of late normal tissue toxicity.
• Converting between fractionation schedules when transitioning from a clinical trial protocol to a standard practice.
• Teaching radiobiology concepts in medical physics or radiation oncology training.

Limitations of the BED Model

• The LQ model assumes a constant α/β ratio, which may not hold across all dose ranges.
• BED does not account for differences in overall treatment time, which can affect tumor repopulation and normal tissue repair.
• The model is less reliable for very high dose per fraction (e.g., stereotactic body radiotherapy with >8 Gy per fraction).
• BED calculations assume complete repair between fractions, which may not be valid for very short interfraction intervals.